Drug name - Dyanavel Xr

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9675703 TRIS PHARMA INC Modified release formulations containing drug - ion exchange resin complexes Mar, 2027

(4 years from now)

US8747902 TRIS PHARMA INC Modified release formulations containing drug-ion exchange resin complexes Mar, 2027

(4 years from now)

US8597684 TRIS PHARMA INC Modified release formulations containing drug-ion exchange resin complexes Mar, 2027

(4 years from now)

US8883217 TRIS PHARMA INC Modified release formulations containing drug-ion exchange resin complexes Mar, 2027

(4 years from now)

US10086087 TRIS PHARMA INC Modified release formulations containing drug-ion exchange resin complexes Mar, 2027

(4 years from now)

US8062667 TRIS PHARMA INC Modified release formulations containing drug-ion exchange resin complexes Mar, 2029

(6 years from now)

More Information on Dosage
Strength Dosage Availability
2MG/ML;EQ 0.5MG BASE/ML SUSPENSION, EXTENDED RELEASE;ORAL Prescription

availability in other generic markets.

Click on the highlighted region to filter.